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Personal health reflects harmony between individual and experience; it is optimal
homeostasis. Disease is an outcome of incongruity leading to dishomeostasis. Relative to
earlier times, disease in modern society has higher "heritability" (in the broad meaning of the
term). Inherited risks are facts compatible with anticipation and prevention of disease. This
viewpoint has major implications for medical practice, deployment of health services, themes
of research, and education of health care personnel and citizens
The Esselstyn Lecture for 1982 is given in the centennial year ofCharles Darwin's
death. Darwin enlarged our understanding of life on Earth; life in all its diversity,
life as the product of an evolutionary process. Nonetheless, Darwin's ideas are not
received knowledge for everyone living in America today. Some of us, being Fun-
damentalists, believe that we are here on Earth according to events ordained by
God.
Fundamentalism has been a potent force in the making ofAmerica [1] and its con-
tinuing presence represents one way to deal with uncertainty in the modern world.
Fundamentalism in modern America is a social movement rather different from its
ancestral premillenialism of Puritan England [2].a The latter mobilized knowledge
and science in preparation for a future. The former, particularly in its guise as scien-
tific creationism, has no such ambition since saving ordained souls for a second
coming is more important than reform that might deviate prophecy. Hence, should
modern Fundamentalism suppress the teaching of genetics in American schools, it
will encourage illiteracy in human biology at a time when such knowledge can be
used to predict and prevent human disease. Such an outcome, to my way of think-
ing, would be contrary to the intent of this lectureship in the twentieth century, to
the founding Puritan ethic ofthe seventeenth century in England, and even contrary
to the ethic of this disputatious young nation in the eighteenth century (see below
aCharles Webster's treatise [2] on science, medicine, and reform in Puritan England (1626-1660) and
Marsden's analysis [1] of the role of Fundamentalism in the shaping of American culture (1870-1925) are
recommended to anyone interested in the place of science in society; our own or those from which we
came.
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and [12]). Since prevention of disease is a principal theme ofthe 1982 Esselstyn Lec-
ture,b the dominant presence of a Fundamentalist ethic in society is a matter of
abiding concern. But before I embark on the main theme we can afford to discover
an ally of Darwin and the theory ofevolution in an unlikely place in an unusual con-
text.
DARWINISM AND EVOLVING KNOWLEDGE
The place is Moscow. The context is an article published on April 19, 1932, in the
Soviet newspaper, For a Communist Education. The author is Osip Mandelstam,
the poet. He is honoring Darwin on the fiftieth anniversary ofhis death. The title of
the article is "On the Naturalists" [3]. Mandelstam is concerned with Darwin's
literary style; his essay ends as follows:
The Naturalist's power of perception is as much an instrument of thought
as is his literary style. Invigorating clarity, like a beautiful day during the
temperate English summer, and acertain quality in the author which could be
called good scientific weather, that is, a moderately elevated mood, work
together in Darwin's writings to infect the reader with the same mood and to
help him comprehend Darwin's theory.
No one can popularize Darwin's theory better than Darwin himself. It is
essential that we study his scientific style, although it is futile to imitate it, for
the historical milieu of which he was a part will never be repeated.
Mandelstam's notebooks [3] of 1931-32 contain these additional lines not used as
such in the final essay.
It was no accident that the most erudite man ofhis age spoke directly to the
broad reading public over the heads of the scholarly caste. It was important
to him to relate directly to this public, and the public did understand Darwin
far better than the scholar pedants. He brought his readers something actual,
strikingly in tune with their sense ofwell-being; he answered a social demand.
These insights, originating in a Communist society of 50 years ago, concerning a
man who worked in a bourgeois capitalist society a century ago, remain modern
because they speak to issues in our own society. Mandelstam believed in the con-
tinuity ofhuman culture and in the value ofknowledge. He appreciated that Darwin's
new paradigm of order in biological systems was linked to a historical perspective
and reflected the needs of the culture from which it sprang.
Darwin worked in a post-Copernican, post-Vesalian culture and with a system of
biological order whose characteristics reflected the overthrow of earlier paradigms.
Ptolemy was replaced in the first context; Galen in the second. Both transitions
reflected replacement of dogma by new knowledge. Darwin was born into and lived
in the period of bourgeois revolutions when there was transition from static
medieval societies to more fluid modern social structures [4]. It is no accident of
history that the static Scala Naturae of Linnaeus gave way to a branched evolving
view of life. One can argue that Darwin was merely a product of competitive
b The Spirit ofMan is the title of an anthology of writings by philosophers and poets, compiled by
Robert Bridges in 1915 in the darkness and stress of The Great War. It went through many printings over
the next 25 years, clearly meeting a need of the reading public. Does anyone of us who delivers the
Esselstyn Spirit ofMan lectures ever draw on our namesake?
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nineteenth-century English society to whom, along with his colleagues, Wells, Mat-
thew, Blyth, Spencer, and Wallace, the idea of natural selection came easily [5]. But
it was Darwin, and only Darwin, who made the evolutionary model so apparent,
documented its process so brilliantly, proposed a mechanism for it, and made it
seem so relevant.
What followed in the wake of Darwinian biology became modern scientific
history. Mendelism resolved the principal difficulty of the Darwinian theory, by
identifying the component of the life process upon which natural selection acted.
Avery, Watson, and Crick characterized that component by discovering the
chemical identity and structure of genes. This new view of life, from the vantage
point of our knowledge about genes, is truly modern since it means that what is new
this year is likely to be old in the next. Theories overturn rapidly; dialecticism is ram-
pant.c Yet, for all the turmoil, the new biology constitutes a system of reliable
knowledge, because it serves as a basis for action and is relevant to choices ofaction
that are important [7]. One dwells on these historical and cultural perspectives
because they are ultimately relevant to prevention of disease in modern society.
THE PATIENT AS MICROCOSM OF EVOLUTION
In Darwinian terms, a successful individual prospers by passing on genes to the
next generation. A successful species is composed ofprospering individuals. Natural
selection acting on the phenotype of individuals is the driving force of speciation.
The Galtonian view recognizes that between species and within individuals there is
measurable variation in one or another phenotypic characteristic; the limits of nor-
mative variation within species can be defined statistically. The prospering organism
maintains the norm as a steady state in various biological functions. The cost of
deviance from the norm is impaired function or disease (Fig. 1) which, in turn, can
impair viability, longevity, development, or reproduction.
Human health represents congruity between the individual (nature) and his ex-
perience (nurture) [8-10]. When there is incongruity, adaptive resilience may be im-
paired and disease can emerge. To understand phenotype in terms ofthe nature:nur-
ture paradigm is not new. But to use the paradigm to predict that heritability of
human disease is increasing relative to what it was is both modern and controversial,
and must therefore be explained as I will attempt to do in due course. Yet, to accept
it offers an opportunity to apply reliable knowledge for the benefit of individuals at
specific (vs. collective) risk to their own health.
The origin of disease is the proper subject of medicine. To understand modern
disease we need a historical view. John Graunt's Natural andPolitical observations
upon the Bills of Mortality, published in 1662, demonstrated that the scientific
method was applicable to human society as a whole and to the understanding of its
apparently haphazard processes-in this case variation in longevity among in-
dividuals living in different parts of London [2]. Graunt observed high mortality in
cReference to Marshall Berman's recent analysis of Modernism and the experience of modernity
[61-under a title found in Karl Marx' CommunistManifesto-is not so out ofplace here as it may seem.
Berman addresses themes relevant to the spirit ofmodern man, particularly the dialecticism between man
and his modern environment. But more relevant still is this passage (p. 346) which, with slight modifica-
tion [words added in brackets] is a refrain of the modern human phenotype and its origins in evolution:
"The primacy ofdialogue in the ongoing life of Modernism [medicine, genetics ...] means that modern-
ists [physicians, geneticists . . .] can never be done with the past [evolution, mutation . . .]; they must
go on forever haunted by it, digging up its ghosts [phylogeny, ontogeny ...] recreating it even as they
remake their world and themselves [and our knowledge of it, of us . . .1."
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FIG. 1. Health as homeostasis (ofbiological function(s)) and disease as dishomeo-
stasis shown in the analogy of a first-class lever in balanced (health) or unbalanced
(disease) positions. The steady state of a specific biological function at equilibrium
reflects interaction with the environment; the mediator (fulcrum) of the interaction
is a gene product. Displacement from the normal equilibrium (in the model) arises
by two independent but interacting mechanisms. In one, displacement (dishomeo-
stasis) occurs when the environmental (extrinsic) force is altered; in the other, it oc-
curs when the(intrinsic) fulcrum is altered. The model illustrates the nature: nurture
paradigm of intrinsic (genetic) and extrinsic (environmental) origins of disease.
infancy, a low mean age for the population, and short average lifespan with a low
frequency oflong-living citizens; he also recorded better life statistics in the suburbs
relative to the city center. Graunt's analyses revealed that human disease in
seventeenth-century London had its principal origins in environmental events. Im-
provement of the human condition would presumably improve individual and col-
lective health. The advent ofpublic health, more than the practice ofmedicine, over
the next two and a half centuries remarkably improved human viability and longevity
in our industrialized nations. Nonetheless disease did not disappear from society; it
merely changed its face.
A given disease- call it a phenotype-has variance. Phenotype and its variance
(Vp) is the result of two interacting sets of determinants each with their own
variance. One set is intrinsic; the other is extrinsic. The first is genetic (VG) with its
origin in mutation; the second is experience with its origin in the environment (VE).
The reader will recognize nature and nurture under different names. The definition
for heritability (of a phenotype) in the broad sensed is the relationship between
variance due to genetic determinants and total variance (h2 = VG/ (VG + VE)). It
follows that to diminish the extrinsic "cause(s)" of any particular disease, without
eliminating the disease altogether, is to increase its heritability in the residual cases
dHeritability has two specific meanings for geneticists. Broad-sense heritability is that proportion of
the variance of a particular phenotype attributable to genetic (vs. environmental) differences. Narrow-
sense heritability is the proportion of variance transmitted directly from parents to children.
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(viz. Fig. 1). To put it otherwise, the relative probability of a particular disease
(phenotype) originating in mutation is higher today than it was in earlier times.
The argument for changing heritability ofdisease is nicely demonstrated in the ex-
ample of rickets [11]. Rickets, a common pediatric condition (and described in
Graunt's Bills of Mortality), was prevalent in northern nations during the pre-
vitamin D era of medicine. Discovery and use of vitamin D (an example of reliable
knowledge) reduced the frequency of rickets but did not eliminate the disease from
industralized society. The majority of rachitic children in modern nations have
Mendelian disorders that affect homeostasis of calcium or phosphorus metabolism.
They have a disease because they have experienced deviation from the normal meta-
bolic steady state; the variance of their phenotype is largely accountable to muta-
tion. Thus, the heritability of rickets, still a "common" disease, has increased in
modern times. The transition from lower to higher heritability in the phenotype is
the direct result of medical science (discovery) and public health (application).
Rickets is a prototype that shows us how we might think about other human diseases
in modern societies.
Mortality andLife Expectancy as Measures ofProgress
For the past three centuries western nations have measured collective health in
terms of mortality rates and life expectancy. The youthful state of Massachusetts
proclaimed, at the founding of its new Medical Society in 1781, that health was
"essentially necessary to the happiness ofsociety" [12]. But even in the newly founded
democratic nation, where health was measurably better than in the parent nations,
there was still cause for concern bytoday's standard. Crude morality rates were 8-28
deaths per 1,000 population and life expectancy at birth was 19-33 years in the New
England communities (Fig. 2A). The early years of life were the dangerous years. If
an adult survived to 30 years he (or she) was likely to live to 52-67 years and if he
reached 70 he would probably outlive 80. By 1900 average life expectancy in the
United States had risen to 47 years, and now it is 73 years. Improvement in longevity
in this century, in comparison with the two previous centuries, reflects improvement
in our passage through the dangerous years of life. As a consequence there has been
a progressive rectangularization of the survival curve [13] (Fig. 2B).
Control of acute extrinsic-origin disease is the principal source of our enhanced
longevity. Fries [13] argues that chronic disease is superseding acute disease in
America; that mortality is being compressed into an ever shorter span of life before
an inevitable occurrence ofdeath at about 100 years. Such considerations led him to
propose a "one-hoss-shay" view of life and death with an implicit hypothesis that
"chronic illness may presumably be postponed by changes in lifestyle" [13]. On the
other hand, if one believes that premature aging and death can reflect breakdown in
DNArepairmechanism [14] or incongruity between genotype and experience involv-
ing critical functions, then we can visualize how heredity may have something to do
with precocious aging and onset of degenerative disorders (e.g., atherosclerosis,
hypertension, diabetes, cancer).
Human mortality in North America now has an interesting age-specific profile
(Fig. 2C). Mortality is very high in utero, high in the prepubertal period of life, low
in the reproductive period, rising exponentially from the fifth decade onward. These
observations implicate a novel view of modern human mortality. In the past, dis-
eases ofinfancy and childhood, largely attributable to causes ofextrinsic origin, ac-
counted for the high pre-reproductive mortality rates. Families compensated by hav-
ing many children. Improved environmental conditions reduced mortality in the
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young; viability increased, fecundity could decline. Nonetheless age-specific mor-
tality remains high in the early years of life relative to the reproductive years. Some
early wastage of life is Mendelian in nature or the result of chromosomal dysgenesis
and congenital malformation. The survivors, individuals that have been selected to
reproduce, do so presumably with reduced mutational impact on their offspring.
Those who develop degenerative illness or die prematurely in the post-reproductive
period have multifactorial phenotypes that are significant for longevity but not for
reproduction. Among all species on Earth, Homosapiens is the only one with a long
post-reproductive period of life [151. Accordingly unhealthy longevity emerges as an
important economic and social burden to modern human society [161.
I have attributed a significant mortality in the early years of life (including the
prenatal period) to Mendelian or gene-influenced disease, chromosomal disorder,
and congenital malformation. A similar profile for morbidity is anticipated. Three
sets ofobservations support this proposition. First, congenital disease is abundant in
pediatrics; up to 50 percent of admissions to North American pediatric referral
hospitals belong in this category [17]; the percentage is smaller in less developed
countries [18]. Second, over 75 percent ofthe disadaptive Mendelian disorders listed
in the McKusick Catalogues [19] are expressed phenotypically by five years of age
(Fig. 3). Third, autopsy studies indicate a high prevalence of gene-influenced and
chromosomal-associated disorders and congenital malformations in pediatric pa-
tients [20], and in spontaneously aborted fetuses [21].
The nature of mortality in the post-reproductive life period is less clearly
characterized. It is fashionable to refer to failure of health maintenance in this
period of life as the product of an unfavorable lifestyle [13]. The term "disease of
lifestyle" implies that wiser living will help us to live longer. A further implication is
that the enemy to health is extrinsic, and related to diet, habits, and experience [22].
According to this view, those who are unhealthy are less moral (in health parlance)
than those who are healthy and long-lived.
However, we do not ask why it is that only some and not all of those who smoke,
drink, or eat profligately develop precocious degenerative disease. We envisage
uniform risk (to the population) in particular experience whereas we could be con-
sidering particular risk (to the individual) in universal experience. We are not ac-
customed to think in genetic terms; we do not accept the biological axiom that in-
Age at Expression of Mendelian Phenotypes
100
80
= 60
FIG. 3. Relation between percent of total and
40 age at which clinical phenotype of Mendelian
disease is established. Data represent 34 X-
linked, 73 autosomal dominant, and 85 auto-
20 somal recessive phenotypes described in McKusick
Catalogues [19]; every third entry describing
0 disadaptive phenotypes was selected. Datareflect
0 0 10 20 30 40 work in progress [Costa T, Scriver CR, Childs B:
Age,years unpublished data, 1982].
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dividual citizens are genetically unique (unless they are a monozygotic twin), each
with a relative state ofhealth within the collective, each potentially at particular risk
for a specific disease depending on genotype.
GENETIC SCREENING: A FORM OF PUBLIC HEALTH
Screening has the potential to identify individuals at risk. A successful screening
test will discriminate apparently well persons in a population who probably have in-
cipient disease from those who probably do not [23].
Genetic screening, to identify phenotype originating in mutation, is a com-
paratively recent development relative to screening for disease in general. Genetic
screening is a search for persons within a population who, because oftheir genotype,
may be at risk for disease in themselves or their descendants, in the universal or a
particular environment. Genetic screening recognizes three broad objectives [24]:
first, to identify persons at risk for their own health and for whom medical interven-
tion could neutralize the harmful effects of gene expression; second, to identify per-
sons at risk for passing a potentially harmful gene to their offspring and who could
benefit from counselling about reproductive options; third, to enumerate frequen-
cies of genetic variants in the population, measure the biological consequences of
such variation, and study its epidemiological significance.
The extent ofMendelian variation in thehuman diploid genome is gradually being
appraised. Genetic polymorphism (meaning heterozygosity with frequency of the
variant allele q > 0.01) expressed as electrophoretic variants among soluble proteins
of blood, is about 7 percent per structural locus per person [25]. The frequency of
variants among the abundant structural proteins of cultured fibroblasts is rather
lower-on the order of a tenth that observed in blood proteins [26]. These are
minimal estimates of polymorphism in different sets of gene products. Protein
polymorphisms are without apparent effect on health in the "normal" environment,
but could be disadaptive in unique environments.
Another measure of human single gene diversity is found in variant Mendelian
phenotypes. McKusick listed over 1,300 human variant phenotypes of proven in-
heritance in the fifth edition ofthe Catalogues [191 with an additional 1,400 or more
ofpresumed Mendelian inheritance. The aggregate number in the forthcoming sixth
edition will exceed 3,300 [McKusick, personal communication, 1982]. The majority
of the "McKusick" phenotypes impair, to some degree, one or other of viability,
development, reproduction, or longevity [Costa, Scriver, Childs: unpublished data,
1982].
If the majority ofthe Mendelian clinical phenotypes are disadaptive under univer-
sal conditions, and if protein polymorphism can sometimes have a harmful expres-
sion in a specific environment (e.g., G6PD deficiency), it follows that to identify
genotype by screening can anticipate disease. Knowledge of genotype under these
circumstances becomes reliable knowledge, as defined by Ziman [7], since it serves
as a basis for action in the medical context, and is relevant for choices ofaction that
are important both to individuals and to society.
Screeningfor Medical Intervention
Screening of the newborn for inborn errors ofmetabolism emerged as a new form
ofscreening for disease about two decades ago. As an innovation in public health, it
was originally intended to prevent certain types of mental retardation. While the
new initiative recognized that mutation could be a necessary condition for certain
types of mental retardation, most of the early projects paid only token attention to
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the hereditary basis of the phenotype and equally little attention to other com-
ponents essential to a successful program. Phenylketonuria [27] represents the pro-
totype experience with newborn screening for a "genetic" disease. Screening for con-
genital hypothyroidism is a recent extension of that experience [28].
Laws were passed in the early days of newborn screening to compel participation,
yet little or no support was provided for diagnosis, follow up, and treatment of pa-
tients identified by screening. The very existence of such an anomaly reveals an inap-
propriate view of the goals of screening. One cannot imagine screening for tuber-
culosis without the ancillary components of a prevention program. Screening itself is
but one component of a larger program serving the common goal [9]. The infant
with a positive screening test must be located; the test must be confirmed, and an ap-
propriate diagnosis assigned. Ifthe subject has incipient disease, counselling must be
given and treatment begun; progress and outcome must be evaluated. Since
genotype is permanent, commitment to the proband is continuous and long-term.
Some health care systems foster the development of integrated programs for preven-
tion of hereditary disease identifiable by newborn screening; others have yet to meet
the challenge [9,24]. The American Academy of Pediatrics [28] recently found it
necessary to reiterate the importance of integrated newborn screening programs, to
accommodate new developments in our knowledge of phenylketonuria and the
prevention of congenital hypothyroidism [28].
Screening for Reproductive Counselling
Screening of Tay-Sachs heterozygotes is the prototype for counselling about
reproductive options [29]. Tay-Sachs disease is untreatable; its impact on patient
and family is great. Prenatal diagnosis is possible and pregnancy termination, when
the fetus is affected, is acceptable to the majority of concerned parents. Screening of
populations, in which the mutant allele is prevalent, has become an effective form of
Tay-Sachs disease prevention, provided follow-up counselling and prenatal
diagnosis are integral components of the program.
Further Applications of Genetic Screening
The prototypes illustrate how population screening for genetic disease can reduce
impact of mutant alleles on individuals and populations (Fig. 4). These early
developments have been cost-effective [301. They suggest that identification of per-
sons at specific risk would be practical for many other Mendelian or multifactorial
disorders during the incipient stages. But whether society is ready for a larger ini-
tiative in this direction is another matter. If surveys on attitudes of participants are
barometers of opinions [9,31-33] some citizens are ready for more genetic screening
and services, even if their physicians are not.
Physicians are less well trained for prevention than for diagnosis and treatment of
established disease and medical education places little emphasis on prevention in
medicine and almost none on genetics [34]. Citizens are also poorly informed about
their own genetic individuality [35,36] and the potential impact of genetic variation
on health maintenance. Furthermore, policies of current government, and some col-
lective attitudes, tend to discourage the development of any initiative in public ser-
vices and education that pertains to genetics. Believing such problems are rare to
begin with, and intractable when found, many would prefer to do nothing, or as lit-
tle as possible. Some have even recommended taking the word "genetic" out of the
term "genetic disease" to avert its presumably pessimistic implication [37].
However, inherited disease has both necessary and sufficient conditions [37,381: a
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FIG. 4. Symbolic diagrams depicting phenotypic impact (cost) of disease (shaded area) on develop-
ment, survival or longevity, and well-being of patient in three prototypes: leftpanel, Tay-Sachs disease;
middle panel, phenylketonuria; right panel, monogenic hypercholesterolemia, heterozygous genotype.
Reduction of impact on proband, family, and society indicated by interrupted line (O-- 0) can be
achieved with screening (solid circle), follow-up, counselling, and treatment (in PKU), or prenatal
diagnosis (in Tay-Sachs disease). Improved outcome for hypercholesterolemia is anticipated when screen-
ing and early treatment are both available and implemented. Some cost is attached to procedures that off-
set mutant gene expression, hence "relaxed" cost is not zero.
component of nature (mutation), a component of nurture (the environmental event
interacting with the gene product). It matters little which condition is sufficient or
which is necessary since both are required for expression of the phenotype; that
is to say, many "genetic diseases" are at the same instance "environmental diseases"
[8,38]. Because this is in fact the case, it is possible to treat certain "genetic diseases"
by modifying the environment: phenylketonuria is the prototype [27]. Without this
example, and others [38], perhaps we would find only "stagnation of research and
treatment" of genetic problems [37], but the opposite is true.
BROADENING THE CONCEPT OF DISEASE PREVENTION:
OLD TERRAIN, NEW MAPS
Neo- Vesalian Anatomy
Vesalius published his revolutionary anatomical plates in 1543 [39]. Dogma was
put aside; the tools of Baconian science applied to medicine gave it new knowledge
and new importance. Four and one-half centuries later, another revoluton in
anatomy is occurring; it is chromosomal and genetic cartography achieved by map-
ping of genes to specific chromosomes and bands on chromosomes [19,40] and the
delineation ofnucleotide sequences in specific genes, respectively [41]. We are begin-
ning to possess chromosomal addresses for Mendelian disease (Fig. 5) and we can
read genotypes in the DNA script.
ChromosomalBandDeletions The establishment, in 1956, ofthe normal diploid
human chromosome number of 46 and the subsequent delineation of banding pat-
terns made it possible to develop karyotype nomenclature and delineate disorders of
chromosomal number or structure associated with disease [42]. High-resolution
chromosomal banding of prometaphase karyotypes in synchronized peripheral
blood lymphocytes represents a more recent technology clearly capable of further
refining the morbid anatomy of human disease. Specific deletions of chromosomal
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segments can be associated with specific Mendelian phenotypes, for example: dele-
tion in the region of band 13 on the short arm of chromosome 11 (del 1 p13) occurs
with the aniridia-Wilm's tumor association [43]; del 13q14 occurs with retinoblas-
toma [44]; del l5ql 1- 13 with the Prader-Willi syndrome [45]. Not all patients with
the eponymic syndrome have the chromosomal phenotype. However, genes for spe-
cific enzymes are closely syntenic with the chromosomal regions in question (cata-
lase on chromosome 11, esterase D on 13, a-mannosidase (perhaps) on 15). Careful
study of these and other syndromes will determine whether enzyme phenotypes can
be used systematically to diagnose the chromosomal phenotype prospectively. This
represents an interesting development in genetic counselling and a novel application
of gene mapping and cytogenetics.
Heritable Fragile Sites Another example illustrates how neo-Vesalian anatomy
can be put to use. Mental retardation occurs in 5 percent of human beings. It is the
most common disadaptive handicap in our society and it has hundreds of causes.
Down syndrome (trisomy21), among the most prevalent forms of"syndromic" men-
tal retardation, is now the prototypic chromosomal disorder eligible for systematic
genetic counselling in the prevention of mental retardation in at-risk population.
Another common syndromic form of mental retardation associated with an abnor-
mal karyotype [46] has recently been found. Males outnumber females in institu-
tions for the retarded, and X-linked mental retardation is more common than Down
syndrome in the male; the former may account for about a quarter of retarded
males. X-linked mental retardation is a heterogeneous phenotype [51] but about half
ofits patients have a heritable, folic-acid-sensitive fragile site on the X chromosome
(fra(X)(q28) phenotype). Assuming that this marker phenotype can be systematically
demonstrated in skin fibroblasts and its biochemical basis delineated, it should be
possible to counsel pedigrees at risk for recurrence. An appropriate advance in
technology might even permit screening of mid-term pregnancies for X-linked and
autosomal [47] fragile sites. This would be another development with considerable
practical (and social) consequences for disease prevention. Gerald [48] goes so far as
to say it is a development with which "every pediatrician must become familiar."
DNA Polymorphisms A recent fortuitous discovery offers yet another method
of forecasting intrinsic risk for disease, in this case by "reading" DNA sequences at
specific chromosomal loci. Kan and colleagues [49] observed a polymorphic site in a
non-coding sequence of DNA adjacent to the 3' end of the ,B-globin locus on-
chromosome lIp. The site was identified with the Hpa I restriction enzyme and a
probe covering the 3-globin locus and the restriction site. It was further noted that a
high proportion of persons with the sickle-cell mutation in the sixth codon of the
first exon in the 13-globin locus were mutant at the Hpa I cleavage site. Since DNA
restriction fragments can be identified relatively easily by the blot-hybridization-
transfer technique ofSouthern, identification of restriction fragment polymorphism
length (RFLP) is a simple way to identify individuals with mutation in the coding
region adjacent to the restriction site, if the two mutations are in linkage dise-
quilibrium.e This approach to proband classification is valid only when population
studies have shown that the RFLP is present at sufficient frequency and pedigree
studies identify its coupling state with the structural mutation gene of clinical in-
terest [50].
'Mutation in the coding sequence of an exon of a structural gene can sometimes be identified directly
by a restriction enzyme. The sickle ,3-globin mutation in codon 6 is detected by the restriction enzymes
DdeIand MstII; for practical reasons, the latter is easier to use. Two groups recently reported use ofMst
IIfor reliablediagnosis ofsickle disease (see editorial by Kronenberg HM: New Eng J Med 307:50, 1982).
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Botstein and colleagues (511 have argued that about 150 carefully selected
cleavage sites containing DNA polymorphisms in the human genone could serve as
markers for most of the structural gene loci and their mutant variants recorded in
the McKusick Catalogues. One new RFLP marker has recently been found in the
proposed "search and define" program [521.
Diseases ofAging
Unhealthy longevity is a macroeconomic burden on industrialized societies [16].
Increasing longevity has impact on pension plans, and chronic illness or premature
death in the post-reproductive adult has profound impact on health insurance
systems. Despite steeply rising disease care costs and slowly increasing longevity in
the past four decades, there has been little initiative to prevent the impact of
unhealthy longevity (Fig. 6). Medical genetics could make a contribution to health
maintenance in the aging population because it has the capacity to anticipate some,
perhaps many, of those at risk for premature onset of degenerative disease.
The biological basis of aging is an enduring but relatively neglected enigma for
which various explanations have been offered (viz. [14] for overview). Weismann
proposed that aging was an adaptive characteristic which allowed natural selection
to operate, so that post-reproductive individuals were removed from the population,
thereby reducing competition with fertile individuals for food and space. Selection
operated, Weismann conjectured, on a programmed limit to mitotic divisions occur-
ring in somatic cells-a hypothesis that anticipated Hayflick by 70 years.
Weismann's hypothesis originated in the context of nineteenth-century thought.
Of course, it was inimical to liberal democratic twentieth-century scientists and
naturally it has been replaced by a new concept-obligate aging. This hypothesis im-
plicates germ-cell mutation as the source ofaging. Since the mutations are expressed
in post-reproductive life in the human species, they must escape selection. Accord-
ingly, that they become fixed by random drift is a necessary component of the
theory.
In its turn, the theory of obligate aging has evoked a counter hypothesis [14] -the
longevity assurance theory-which states that longevity in mammalian species is
proportional to the ability of the organism to repair its DNA. The repair apparatus
is inherited in Mendelian fashion. The hypothesis is supported by considerable
evidence, and specific Mendelian failures of DNA repair are an occasional source of
premature senescence in man [14,19].
Our principal concern here is to find a universal explanation that accommodates
rloo
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0 FIG. 6. Trends in life expectancy
prevention expenditures (dotted line), national health expendi-
h tures, and prevention expenditures,
1940 1960 1975 since 1940, in U.S.A. Costs are calcu-
lated in constant 1967 dollars (taken
(from Gori & Richter 1978) from Gori and Richter, [16]).
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not only the process of normal aging but also the heterogeneous pattern of precipi-
tant diseases of aging. It seems improbable that atherosclerosis, coronary heart
disease, chronic pulmonary disease, stroke, cancer, diabetes mellitus, and
Alzheimer's disease, to mention only a few phenotypes, can all be attributed to
failures in DNA repair originating in mutation at the few loci responsible for the
repair apparatus. On the other hand, we have clear evidence that Mendelian in-
heritance at many loci is associated with precocious aging; and, more importantly,
this information can be used for preventive measures.
Aging, in many instances, reflects the consequences of metabolic dishomeostasis.
Intrinsic events interacting with the "normal" environment (Fig. 1) initiate disho-
meostasis, setting in motion a train of chronic events that leads to pathological
aging. Knowledge of receptor-mediated endocytosis at the plasma membrane of
somatic cells [53,54] reveals how a Mendelian event can alter cellular and metabolic
homeostasis and shorten longevity in the vulnerable individual (Fig. 7).
Cholesterol dishomeostasis is one of the causes of atherosclerosis [55]. Impair-
ment of receptor-mediated endocytosis of LDL-cholesterol in the phenotype known
as type II familial hypercholesterolemia increases the endogenous burden of
cholesterol [56]. The steady-state serum cholesterol level is increased two- to three-
fold in heterozygotes who bear any of the dominantly inherited alleles that disturb
cholesterol endocytosis. The frequency of such heterozygotes is 1 in 500 in the
population at birth. Because their genotype places them at elevated risk for
atherosclerosis, heterozygotes appear at elevated frequency among those who
develop coronary heart disease before the age of 60. Such persons are said to be 3
percent of surviving patients in coronary care units [57].
If we adopt a fatalistic attitude to monogenic hypercholesterolemia, believing it is
untreatable because it is genetic, or that it is a form of obligate aging, we will com-
mit such persons to premature unhealthy longevity; their family history will be a
curse. Superstition will prevent action. In desperation we might recommend a strin-
gent (moral) lifestyle designed to reduce the cholesterol burden. Unfortunately, that
course ofaction will have little effect becausethe steady-state synthesis and degrada-
tion of cholesterol in the mutant state is set to compensate for any extrinsic adjust-
ment. Accordingly, treatment will fail, fulfilling the prophecy that nothing can be
done for genetic disease.
On the other hand, because we are informed about the mechanism of cholesterol
dishomeostasis in type II familial hypercholesterolemia, it is possible to design
therapy that bypasses the defective receptor and down regulate cholesterol biosyn-
thesis to the normal level; fractional clearance ofcholesterol can also be increased by
pharmacological tricks [58]. Such therapy shows preliminary evidence of success
[59]. The next step toward preventing premature coronary heart disease in this
monogenic phenotype will be to develop a test for defective receptor function in
heterozygotes. The final step will be long-term studies of prospectively treated
heterozygotes to determine whether the mutant phenotype can be completely
neutralized, accelerated atherosclerosis prevented, and the threat of precocious,
unhealthy longevity lifted. Here then is a dramatic illustration of a high-burden,
common disease ofaging that is potentially eligible for prediction and prevention. It
illustrates the axiom that disease reflects specific (individual) risk in the universal en-
vironment.
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CHD
FIG. 7. A profile of mortality due to heart disease. Coronary (ischemic) heart disease
(fully shaded sector, panel A) accounts for over 40 percent of premature mortality in
North America. Atherosclerosis (panel B), the major pathogenetic mechanism of
ischemic heart disease, is heterogeneous in origin [57,70]. About half surviving patients
with premature myocardial infarction are hyperlipidemic. Monogenic hyper-
cholesterolemia is one cause of hyperlipidemia. Type II familial hypercholesterolemia
heterozygotes have disordered absorptive endocytosis of LDL-cholesterol (panel C);
various alleles at one or more loci account for various mechanisms of aberrant receptor-
ligand interaction. R gene (for receptor) has three function domains; ligand component,
banding B; transmembrane core, C; cytoplasmic locator, L. RL Gene (for receptor
locator) is presumable at independent locus. Phenotypes shown are: zero,' or deficient, ;
symbols: b, binding; i, internalization (see [561 for details).
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MOVING FROM CHANCE TO PURPOSE:
RECOGNITION OF INHERITED RISK
Age-specific mortality and morbidity due to stroke and coronary heart disease
have, in fact, improved in the past two decades [60-62]. Mortality in the newborn
nursery has also declined and more low-birth-weight infants are surviving [631.
These achievements could be construed as victories for the environmentalists. One
can also see them as worthwhile achievements that inevitably increase theheritabilityd
of disease in the survivors at both poles ofthe human life span. Moreover, if disease
is a combinatorial product of interactions between genotype and experience it
follows that to optimize the environment to suit a universal population can only
eliminate that fraction of disease originating in universal experience. In other words,
maximizing experience to minimize disease (the public health paradigm) must have
diminishing returns; the irreducible disease burden that persists after we have har-
monized the world will ultimately reflect individualized dishomeostasis of intrinsic
origin.
The dilemma of persisting disease in a better world-of precocious, unhealthy
longevity and a rising proportion of birth defects in the total disease burden-
remains a challenge waiting to be recognized and met. Some have pondered it.
Among them Wynder, then President of the American Health Foundation, opined
that "in public health, the best question is one that can be answered and whose an-
swer can be applied to the reduction of disease. Thegreater the impact on health, the
better the question" [64] [my italics]. Wynder was not, to my knowledge, thinking
about genetic medicine as an answer to his call. In a similar vein, Comar, discussing
risk acceptance and the move from the world of facts to the world of values, stated:
"we can predict statistical effects on populations [but] there is no way to predict ef-
fects on individuals" [65]. If we take these statements at face value we might deny
furtherprogress in, for example, genetic screening programs, or in the possibility of
preventing premature ischemic heart disease in specific individuals. Environmen-
talists and critics ofthegenetic viewpoint would consider my examples esoteric, rele-
vant to but a few patients at any one time-just not in the mainstream. To counter
thatobjection, I propose a small list of"common" and "important" diseases (Table 1).
Each is aphenotype heterogenous in origin. Some patients-the majority perhaps in
some phenotypes-have the disease because of their genotype. Such persons are at
particular risk and develop their particular disease in the universal environment. We
are reminded that prevention of disease in probands, or of recurrence in relatives,
might be possible if the risk attached to genotype is identified at the incipient stage
and the lifeexperience modified to fit the constraints to health imposed by genotype.
Sudden Infant Death Syndrome (SIDS) This condition is the most-common
cause of death in infancy after the first month of life. It affects two or three infants
per 1,000 and exhibits noteworthy racial and regional variation. It is considered a
multifactorial event [66]. There is no evidence of Mendelian inheritance in the ma-
jority ofcases, but in some infants with near-SIDS, there are identifiable abnormal
phenotypes inventilatory and respiratory function; these abnormalities may also be
present in one or both parents in some families [67]. In such families subsequent sibs
would be prime candidates for theophyline therapy or electronic monitoring, par-
ticularly ifthey exhibit thehigh-risk phenotype. This is not a global prescription for
SIDS; it merely recognizes heterogeneity in the syndrome. It could be considered a
rational form of intervention and support at acceptable cost for a devastating prob-
lem in some families.
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TABLE I
Multifactorial Common Disease with Familial Component
Mendelian or Heritable
Principal Impact on Medical Phenotype Components
Viability Sudden Infant Death Ventilatory response to
Syndrome CO2; periodic breathing
Impaired development Neuropsychologic Fragile X (q28);
defects Autosomal fragile sites;
Heterozygosity for
metabolic disorders
Unhealthy longevity Atherosclerosis Monogenic and polygenic
hypercholesterolemias
Major psychoses HLA haplotype; neuro-
endocrine homeostasis
Alcoholism Ethanol metabolism;
Transketolase binding of
thiamine pyrophosphate
Iron overload Hematochromatosis
(and HLA haplotype)
Osteoporosis Lactase-deficient
(post-menopausal) phenotype
Cerebral Dysfunction Cerebral dysfunction associated with X-linked and
autosomal fragile chromosomal sites was mentioned earlier. Other forms of im-
paired CNS development are associated with heterozygosity. Females heterozygous
for X-linked deficiency ofornithine transcarbamylase are at elevated risk for modest
intellectual deficits, perhaps as a consequence of episodic hyperammonemia [68].
Identification of carriers of the gene in pedigrees in which the gene is segregating
constitutes prediction of persons at risk. Modification of protein intake to fit the
tolerance of these subjects, which can be monitored by urinary excretion of orotic
acid, could prevent disadaptive development.
Heterozygotes for various lipidosis are also said to have modest neuropsycho-
logical consequences of their phenotype [69]. Whereas these findings are the result
of a pilot study, they illustrate the theme that heterozygosity can be a risk factor. In
this case, no feasible form of preventive medical treatment seems available but ac-
curate prenatal identification of heterozygotes might represent reliable knowledge
for some families, and postnatal identification might lead to special educational
measures whose outcome could at least be studied prospectively.
Atherosclerosis Among the universally recognized typological classifications of
disease, atherosclerosis is a pathological process of immense complexity [70]. It is
the most common lethal disease in the adult population; it has no single cause.
Hypertension, cigarette smoking, hyperlipidemia, gender, and alcohol all contribute
to expression of the atherosclerosis phenotype. In the genetic paradigm of disease,
atherosclerosis is the outcome of events emanating both in the environment and in
the organism. Those that provoke dishomeostasis of lipid metabolism lead to
atherosclerosis. There is, for example, a spectrum in the distribution ofpredominant
causes in the cholesterol-dependent forms of atherosclerosis (Figs. 7 and 8). Exorbi-
tant chronic intakes of cholesterol are atherogenic to persons with apparently nor-
mal genotype, and monogenic events impairing receptor-mediated uptake of LDL-
cholesterol are also atherogenic in the presence of normal cholesterol intake. It is
now apparent that other single gene mutations influence cholesterol homeostasis
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FIG. 8. Hypothetical distribution of
GENETIC individuals with the atherosclerosis GENETIC
phenotype leading to precocious cor-
FH/FH onaryheart disease(CHD).When geno-
type is the predominant "causal"
event, individuals are placed at the
FH/+ 6t~~~~~~~~~genetic" end of the spectrum; when
environment predominates, they are
FH/4b,X)!^^1 / ,_ / placed at the other pole. Subpopula-
tions A-D represent individuals whose
rz + / / phenotypes reflect combinations of
>"causes" in the relationship P = G +
Z/2+CHOL i E (phenotype = genetic + environ-
ment). Individuals at the upper end of
spectrum have high heritability of
phenotype (h2 = VG/VP, where V =
4+CHOL variance); those at opposite end have
CHiD | ENVIRONMENTAL low heritability. FH/FH indicates
homozygous monogenic hypercho-
lesterolemia (receptor deficient form or familial hypercholesterolemia Type II); 4 + Chol indicates
profligate dietary burden of cholesterol. Most subjects are FH heterozygotes (FH/+), multifactorial
(FH/ +,X), or polygenic X + Y + Z in origin of phenotype.
[71,72] and that different monogenic events can interact to cause polygenic
atherosclerosis.
The message in atherosclerosis is universal, not necessarily specific: recognition of
genotype is a form of taxonomy. Classification by itself, however, is insufficient; it
merely explains why this person has this or that "disease." The power in recognition
of genotype is the predictive component; it anticipates disease. Since the disadaptive
gene must express itself in an environment, to identify genotype is the first step to
prevention-by modifying the macroenvironment of the person or the microen-
vironment of cellular homeostasis [73].
Psychoses Behavioral genetics is an area of major importance, inadequate still
in theoretical constructs yet immense in implications. The major psychoses are
transcultural disorders that affect large numbers of citizens in all societies. Schizo-
phrenia and the affective disorders are undoubtedly both heterogeneous, both
typologies probably embracing several specific diseases. Heritability of the
psychoses is high, concordance being higher in monozygotic twins, whether reared
apart or together, relative to dizygotic twins [42]. This finding indicates that the ma-
jor psychoses, non-Mendelian in the aggregate, may yet yield to genetic analysis in
their components. In fact, thedepressive psychoses, when classified into bipolar and
polar forms, seem to have differentdegrees ofheritability and expression in relatives
[42], and schizophrenia has at least one minor but clearly Mendelian form that is ap-
parently both detectable and preventable [74].
Phenotypic subclassification will be as relevant and important in the major
psychoses as it is now in atherosclerosis; when Mendelian forms are recognized, ab-
normal gene products are more likely to be discovered; with a biochemical marker
identified, the opportunity for specific therapy is offered; detection of persons at
risk and prevention ofdisease arepotential realities. In this hypothetical context, the
recent finding of apossible association between HLA haplotype and susceptibility to
depressivepsychosistentatively suggests that a locus on chromosome 6 is involved in
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the pathogenesis of affective illness [75]. If the association of haplotype with
behavioral phenotype is not one of cause and effect, it might still prove useful in
identifying persons at risk.
Alcoholism Epidemiological studies in three countries (Sweden, Denmark, and
the United States) indicate that genetic factors and environmental influences are
both involved in the pathogenesis ofalcoholism (viz. [76,77] for details). One author
calls alcoholism a "pharmacogenetic disorder" [77]. Genes influence the metabolism
of ethanol itself and also the response of specific cellular events (e.g., in liver or
brain) in the alcoholic. Genetic components of alcoholism, in the opinion of some,
offer special opportunities to intervene beneficially in high-risk situations. For ex-
ample, blood acetaldehyde concentrations are higher after an ethanol load in young
non-alcoholic men with an alcoholic parent or sib, compared to matched controls
without an alcoholic relative [78,79]; transketolase binding of thiamine
pyrophosphate is attenuated in cultured skin fibroblasts and erythrocytes in vivo in
patients with the Wernicke-Korsakoff syndrome relative to controls without the syn-
drome [80]. The first finding [78] was statistical in nature; it was not stated whether
individuals in the experimental group segregated into those with an abnormal
response and those without, suggesting a bimodal (Mendelian) phenotype; should
that eventually prove to be the case, it might then be possible to anticipate family
members at high risk for alcoholism and to counsel avoidance measures. In the sec-
ond example [80] it is implied that a constitutional phenotype predisposes to
development of the Wernicke-Korsakoff syndrome in chronic alcoholics; the ap-
propriate pedigree studies have not yet been done to determine whether the
biochemical phenotype segregates in Mendelian fashion and is expressed in non-
alcoholic relatives. In the meantime, the finding implies that specific thiamine
therapy might prevent development of psychoses in established alcoholics who have
the thiamine-dependent phenotype; this constitutes specific preventive therapy and
it is the approach which is radically different from a proposal to fortify all alcoholic
beverages with thiamine [81]. The latter assumes uniform risk in the universal
population whereas the former infers specific risk in particular persons. One is a
conventional public health approach to prevention of Wernicke-Korsakoff
psychosis in the population; the other applies the principles of genetic medicine.
Hematochromatosis/lIron Overload I was taught, in my undergraduate medical
studies, that hemachromatosis is a rare disease of minor clinical importance; its in-
terest lay in a display of classical elements of pathology. No one told me the disease
was inherited; no one mentioned the risk of iron overload in heterozygotes. That
was long ago; the view of hemachromatosis has changed [82]. Students of the
disease now believe it is the expression of(a) mutant allele(s), inherited in autosomal
recessive fashion, at a locus tightly linked to the HLA region on chromosome 6 (that
locus again!); linkage studies confirm that the susceptibility allele is in disequilibrium
withthe HLA-A3 haplotype [83]. Thephenotypicexpression ofthe"hemachromatosis
gene" involves excessive intestinal absorption of dietary iron, but the mutant gene
product is unknown at present. HLA typing can identify homozygotes at high risk
for disease in adult life; it is uncertain whether a test for heterozygosity is possible
but further research on this problem is warranted. Whereas homozygosity is rare,
Hardy Weinberg equilibrium and population studies suggest that 10.4 percent of
Utah Mormons, 9.5 percent of Breton French, and 8.4 percent of Scots are hetero-
zygous for the hemachromatosis allele [84]. If such persons are susceptible to
modestly enchanced iron absorption and the pathological consequences thereof, it
follows that male heterozygotes in particular could experience iron overload. Iron
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medication, high consumption ofwine, even iron fortification in bread [84] could be
disadvantageous to heterozygotes. The polymorphic status of the hematochromatosis
gene implies selective advantage for the allele itself (particularly in females), "hitch-
hiking" of the gene with tightly coupled advantageous HLA haplotype in human
evolution [84], or even a founding effect in Celtic and Mormon populations. That
was long ago. The allele is an intrinsic risk factor of clinical significance in the
modern world.
Osteoporosis Osteoporosis is the most prevalent form of metabolic bone disease
in man, yet it remains an enigmatic, expensive, and disabling condition. The disease
is undoubtedly heterogeneous in origin. A recent study [851 of post-menopausal
idiopathic osteoporosis indicates how intrinsic factors may increase risk for the
disease. Intestinal lactase deficiency is more prevalent in the post-menopausal
disease than in control subjects. Lactase activity, in some way, enhances calcium ab-
sorption. Lactase-negative individuals are presumed to have altered calcium absorp-
tion and thus may be predisposed to osteoporosis. The lactase phenotype (positive
or negative) is polymorphic in the human species. Populations indigenous to
temperate geographic regions are predominantly lactase-positive. Individuals in
these populations who are lactase-negative may be at risk for osteoporosis. The
observations merit further study and the availability of a simple test for lactase defi-
ciencyprovides a simple method to do so and perhaps, eventually, to predict persons
at risk for osteoporosis. Studies in populations indigenous to tropical regions are
also indicated to discern whether adaptive mechanisms for calcium homeostasis,
that are not lactase-dependent, protect such persons from osteoporosis. Thus we see
that a major polymorphism, with apparent adaptive significance for man [86] might
become relevant to the interpretation of a common disease.
DARWINIAN HUMAN BIOLOGY: MEDICINE TRANSFORMED
The temporal parameters ofhuman life are diffeent from those ofother mammals
and primates [15]. Humans have a relatively long intragestational period of fetal
development that produces single or occasional multiple precocial offspring.
Postnatal, pre-fertile development is also long. The reproductive period itselfis only
a portion of total lifespan; post-fertile life is again long-for a few in earlier times,
for many in modern societies. Our extreme precocial development is compatible
with attainment of a large brain [87] but only if our evolution as a species (i.e.,
through development ofindividuals) can occur under very stable environmental con-
ditions. Maternal metabolism and the conditions of early postnatal life assure that
this is so [87]. Our large diploid genome, shuffled continuously by sexual reproduc-
tion, and its capacity for repair [14], are compatible with large interindividual varia-
tion and yet relative stability of intrinsic determinants. Upon this biological system
selection by consequences is at work perhaps in a three-tiered mechanism [88]: Dar-
winian selection, acting on individuals, unquestionably shapes our biological nature;
selection by operant conditioning may influence our behavior; selection through
learning, verbal or written expression, appears to influence evolution of culture,
both in animals [89] and in man [90].
Since mutation is the fuel of diversity, whereas homeostasis is the engine of sur-
vival, we are, perforce, interested in the impact of mutation. Mutation load-a
population statistic-has appeal because of its simplicity. But it has limited use in
medical genetics because the only measure ofits impact is on survival and fertility; it
is measured only in Darwinian fitness and does not measure impact on human
welfare. Mutation component-a new term defined by Crow [91,92]-considers
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more than biological fitness. It refers to the proportion of the incidence of disadap-
tive disease accounted for by recurrent mutation; it considers the origin of
phenotypes with normal distributions for which the optimum value is intermediate
between extremes. In other words, it can address the origins of deviance in
homeostasis byconsidering heritability ofphenotype in broad and narrow senses.d If
narrow-sense (Mendelian) heritability for the particular phenotype is high the muta-
tion component is high and increase in mutation rate, by whatever means, produces
a rapid response in mutation impact (meaning deleterious effect on human welfare);
the milder the effect, the more the impact is spread over time. If narrow-sense
heritability is low the response to increased mutation rate is small and slow [91].
It has been a recurring theme in this lecture that, within the overall distribution of
a "disease" phenotype in the population (e.g., atherosclerosis), broad-sense herita-
bility has increased in modern times; yet, within the collective phenotype we can
identify subjects of phenotype with high narrow-sense heritability (e.g., monogenic
hypercholesterolemic atherosclerosis). This view suggests a greater need for genetic
epidemiology in the study of modern diseases. Accordingly, we need data on
prevalence, incidence, and social cost of disease. We also need record linkage to
study correlates between relatives for disadaptive disease.
The perceptive reader will see that this approach can monitor new mutations in an
era whose environment is in danger of increasing mutagenic pollutants. But a by-
product ofrecord keeping is simple enumeration ofgene-influenced disease. It is be-
ing done now in some populations [93,94] with the startling discovery that the fre-
quency of non-chromosomal hereditary disease is between 5 percent and 10 percent
of live births. The World Health Organization [95] is evaluating ubiquity and
burden ofgenetic disease and considers it a problem that warrants measures for con-
trol and prevention as well as services for management ofgenetic disabilities. A call
to action from the WHO is a far cry from recourse to prayer (which Galton showed
to be singularly ineffective in altering phenotype [961) or pessimism [37]. It is the
new epidemiology.
PREDICTIONS
It is ironic, and yet appropriately modern, I suppose, that there is any gap what-
soever between what we need and what we have in genetic medicine. There are clear
and present needs but their attainment will probably be delayed more than is
desirable unless we drive a troika of research, services, and education.
Research The fructifying influence of research on medicine is well-documented
[97,98]. In the aggregate, medical science is reliable knowledge. One requires only
modest clairvoyance to predict how research in human genetics should benefit
medicine in the next generation-the beginning of the second Darwinian century.
i. All-or nearly all-human genes will find their places on the chromosome
map, the nucleotide sequences of many will be described, and regulation of
their expression delineated much more precisely than is the case now.
ii. The mechanisms of ontogeny will be better understood; accordingly, the
origins of certain congenital malformations will be surmised.
iii. DNA polymorphisms in non-coding regions will be delineated to permit map-
ping ofpredictors of disadaptive clinical phenotypes associated with adjacent
structural loci.
iv. Treatment for disadaptive phenotypes will improve because the tailoring of
nurture to fit particular natures will be refined. Nutrition and pharmacy will
attain new dimensions.
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v. Gene therapy will not be ignored: present novelties such as the potential for
design and use of suppressor genes [99] and the cloning and insertion, by
transgenic methods [100], of normal genes into mutant germ cells, will be at-
tempted in man. In vitro fertilization techniques will be essential for such
developments. People will initially fear these developments as much as they
did pasteurization, vaccination, fortification of natural foods, and use of
drugs and antibiotics; but reason supported by evidence will prevail.
Resources and Services Knowledge without application can be beautiful but
sterile. Services to utilize knowledge constitute societal resources. Despite evidence
that genetics services help citizens [9,24], development on this front has been slow. I
predict that genetic screening, suitably integrated into programs, will become a
greater systematic resource in public health and private medicine.f Screening and
diagnosis allow individuals to convert uncertainty (probability) to prediction (binary
statements about presence or absence of intrinsic risk). Nonetheless moral persua-
sions and fiscal fervor are, at this moment in America, imposing values held by some
on others who care to know-and need to know- how to make choices that matter
for their personal lives. Services that are needed (e.g., prenatal diagnosis) are being
denied or withdrawn because there is controversy over values. When the fact of
genetic diversity and specific need is ignored, citizens will suffer. We need wisdom to
steer a better course. Assuming wisdom will prevail over fundamentalism and par-
simony, we can anticipate expansion of genetic services [9], registers [101], and
record linkage [94]. Formal economic analysis [30] will adequately defend these
developments by demonstrating cost effectiveness.
Education Bromley [102] considers education another frontier of science:
"Public scientific literacy is a necessary-if far from sufficient-condition for
development of the new constituency for science and technology."
Recruitment of geneticists, who will do research and apply knowledge, begins in
the formative years-spent in school. Citizens, who will benefit from genetic knowl-
edge, have a universally shared opportunity to learn something about their own
biology-in school [35,36]. How ironic that the teaching of genetics is, once again
[103], being turned off in the classrooms while textbooks are being expurgated of
their material on human genetics and evolution.
Nor can we hope that physicians will be more literate and therefore act as more in-
formed arbiters of knowledge and application. Our medical curriculum is barren of
much exposure to medical genetics [34]; its web ofgenetics teaching has a gossamer
quality. Accordingly, if the blind are leading the blind we are in dire need of
enlightenment. Curriculum revision, more post-graduate residencies in medical
genetics, a larger number of traineeships and fellowships (funded by government
agencies and private sources-perhaps even by health insurance carriers) would
brighten the path.
CONCLUSION
Homo sapiens possesses a "nested set of characteristics" [104]: we share with all
mammals three middle-ear ossicles; with all vertebrates, a backbone; with all
fA Subcommittee on Investigation and Oversight of the Committee on Science and Technology U.S.
House of Representatives (97th Congress, Hon. Albert Gore Jr., Chairman) recently held hearings on
Genetic Screening and the Handling of High-Risk Groups in the Workplace (October 14, 15, 1981; Pro-
ceedings published by U.S. Government Printing Office, Washington, DC, 1982). Here is a bread-and-
butter issue; not genetics and life or genetics and family planning but genetics andjobs. Issues, practices,
and misadventures are aired. The Proceedings are interesting reading.
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eukaryotes, nucleated cells; with all living organisms, cellular RNA and a plasma
membrane. Our journey of descent with modification implies that life on Earth
possesses a biological memory, relatively stable yet capable of modification and
amplification. Genes are the map of our journey. Human genetics is a voyage of
discovery.
Disease reflects the evolutionary process. Health is diversity with harmony;
disease is disadaptive dissonance-incongruity between genotype and experience-
dishomeostasis. In increasing proportion, relative to earlier times, disease in modern
society reflects our mutations. Disadaptive phenotype is expressed maximally in
utero and in early life, but also later in life as we age. Selection and adaptation are
measured in biological, behavioral, and cultural terms. We arethe product ofcollec-
tive and personal events. In living out our term we contribute to and become part of
biological history.
Mandelstam, who understood so well the importance of Darwin, felt deeply the
meaning of human life and culture. Let the words of poem number 8 in his opus
[105], written in 1909 when he was eighteen, be the last addressed here to the Spirit
of Man in a troubled world.
What shall I do with the body I've been given,
So much at one with me, so much my own?
For the calm happiness of breathing, being able
to be alive, tell me where I should be grateful?
I am gardener, flower too, and unalone
In this vast dungeon
My breath, my glow, you can already see
On the window panes of eternity
A pattern is imprinted here
Unknown till now.
Let this muddle die down, this sediment flow out.
The lovely pattern cannot be crossed out.
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